FREE Case Review (866) 588-0600

New Jersey Mounjaro Stomach Paralysis Lawsuit (Latest Updates)

Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt
Free Confidential Mounjaro Stomach Paralysis Lawsuit Review
If you or a loved one suffered from stomach paralysis or another injury after taking Mounjaro or another weight loss medication, you should contact our lawyers today.

You may be entitled to compensation by filing a Mounjaro Stomach Paralysis Lawsuit and our lawyers can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm today by dialing (866) 588-0600.

Start My Free Case Review

Quick Summary

  • If you’re dealing with stomach paralysis potentially caused by Mounjaro, you’re not alone. The topic of the New Jersey Mounjaro stomach paralysis lawsuit is crucial to you.
  • This article provides a clear overview of the legal situation, helps you understand your rights in New Jersey, and guides you through the steps if you’re considering legal action. We aim to prepare you to navigate this complex issue with the necessary facts and assistance.
  • If you or someone you know has been affected by complications from Mounjaro, Schmidt & Clark, LLP, is here to assist you. Renowned for our proficiency in plaintiff representation, our main objective is to ensure you obtain the justice and compensation you rightfully deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by offering seasoned legal warriors at your side, making your fight against a health crisis aggravated by a medication like Mounjaro not just comforting but strategic. S&C Law Firm, with its deep-rooted expertise in gastrointestinal disorders and related medications, emerges as a formidable ally in Mounjaro’s stomach paralysis claims.

The firm’s resources are equipped to:

  • Investigate, evaluate, and pursue claims related to medication-induced adverse effects
  • Take on new challenges with experienced attorneys in individual litigation nationwide
  • Provide guidance and representation to affected individuals
  • Utilize their expertise in mass torts to develop strong product liability lawsuits against pharmaceutical companies

Mounjaro Stomach Paralysis Lawsuit

In recent years, there has been an increase in cases of gastroparesis, a condition of stomach paralysis, in New Jersey.

At the center of this medical problem is the diabetes drug Mounjaro, now linked to this debilitating ailment. The implications are far-reaching, and the response has been swift and legalistic, with lawsuits piling up against the drug’s manufacturer, Eli Lilly, for their alleged role in this health crisis.

Central to these legal battles is the claim that Eli Lilly failed to provide adequate warnings on its Mounjaro labels about severe side effects like gastroparesis. The allegations extend to the pharma giant’s neglect of the potential for serious gastrointestinal effects, leaving patients vulnerable.

While the legal proceedings continue, individual stories, such as a woman suffering severe gastrointestinal side effects after being prescribed Ozempic, highlight the personal toll. These narratives emphasize the real suffering behind the legal jargon.

Similarly, the Ozempic lawsuit has brought to light numerous cases where patients experienced adverse effects, including severe gastrointestinal issues.

The legal claims against Ozempic’s manufacturer, Novo Nordisk, allege that the company failed to provide sufficient warnings about the potential risks associated with the medication.

These lawsuits are not just about financial compensation; they are about holding pharmaceutical companies accountable and ensuring that patient safety is prioritized.

Although not part of an Ozempic class action lawsuit yet, the stage is set for a significant courtroom drama that could reshape prescription medication litigation, including potential Ozempic lawsuits.

What Is Mounjaro?

According to Healthline, Mounjaro is a recently approved diabetes medication that also significantly reduces weight. Its active ingredient, tirzepatide, is a trailblazer in its class, acting as a dual agonist for both GLP-1 and GIP receptors [1].

Unlike its semaglutide-based cousin, the diabetes drugs Ozempic and Wegovy, Mounjaro stands out by targeting two receptors, promising a revolution in diabetes management and obesity treatment.

Yet, Mounjaro’s promise of weight loss comes with significant risks. Despite not being FDA-approved for weight loss, clinical trials have shown that its highest dosage can lead to notable body weight reductions, as much as 21%.

Administered once a week, this injectable medication, one of the weight loss drugs not yet approved, offered hope for individuals with elevated BMIs, but it has also been associated with unforeseen and serious side effects.

Was Mounjaro Recalled?

Mounjaro was not recalled amidst these troubling revelations. When the FDA granted its approval for Mounjaro as a Type 2 diabetes treatment on May 13, 2022, it did so with eyes wide open, acknowledging the increased risk of gastrointestinal side effects.

The medication’s black box warning advises against its use for individuals with a history of thyroid carcinoma or endocrine neoplasia syndrome.

The FDA continues to monitor Mounjaro through its Adverse Event Reporting System, identifying potential safety risks and analyzing adverse event reports. This ongoing evaluation is part of the FDA’s commitment to ensuring the safety of medications on the market, including monitoring for any reports of serious side effects such as suicidal thoughts or actions [2].

Mounjaro is not approved by the Food and Drug Administration (FDA) for use as a weight loss drug. But because the drug is prescribed along with exercise and a balanced diet, some people may lose weight during their Mounjaro treatment – Amber Watson, PharmD, BCMAS, Assistant Medical Director at NashBio

Side Effects of Mounjaro

The impact of Mounjaro is shaped by its side effects, with gastroparesis at the forefront. This condition, more common in women, can significantly impact quality of life, causing symptoms such as nausea, vomiting, abdominal bloating, and abdominal pain.

This form of stomach paralysis, more prevalent in women, can drastically diminish life’s quality, leaving sufferers in a constant battle with symptoms like:

  • nausea
  • vomiting
  • abdominal bloating
  • pain

Diabetes, the very condition Mounjaro is intended to treat, is ironically also a known cause of gastroparesis, entangling the drug in a web of painful irony.

According to Mana, the complications from gastroparesis are serious. Severe dehydration, malnutrition, and bezoars, which can be intestinal blockage of food passage into the small intestine, are significant risks, potentially leading to bowel obstruction [3].

Mounjaro’s prescribing information warns against its use for patients with severe gastrointestinal issues, including gastroparesis. Yet, reports of such side effects persist.

For those affected by stomach paralysis after using Mounjaro, the consequences are distressing. It’s a stark reminder of the risks involved in managing health with prescription medications.

How Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit?

To qualify for a Mounjaro stomach paralysis lawsuit, you must be able to prove a direct connection between the drug and your injury. This involves demonstrating that Eli Lilly failed to provide adequate warnings about the risks of adverse medical events, particularly gastroparesis.

Eligibility extends to those who have experienced severe gastrointestinal injuries after using Mounjaro. The multidistrict litigation (MDL) includes not just Mounjaro but also its pharmaceutical kin, the diabetes drug Ozempic, both GLP-1 receptor agonist drugs with a shared defendant in Eli Lilly and Novo Nordisk.

These weight loss drug lawsuits challenge the adequacy of warnings provided and seek to hold the drug manufacturers accountable for the distress caused.

The Status Of The Mounjaro Lawsuit Litigation in New Jersey

The legal situation surrounding Mounjaro in New Jersey involves examining diabetes treatments, potential side effects, and legal scrutiny. Courts and the Food and Drug Administration are reviewing how these medications, including GLP-1 receptor agonists like Mounjaro, affect patients.

The litigation is currently in its early stages, with no settlements or trials on the horizon, but there is anticipation about the outcomes of these cases.

The plot thickens with the advent of multidistrict litigation (MDL), a legal mechanism that consolidates individual Mounjaro lawsuits for pre-trial proceedings in a single United States District Court. This approach aims to streamline the process, create uniformity in rulings, and facilitate the sharing of crucial information.

The MDL’s ripple effects, which include at least 55 lawsuits, are significant for New Jersey. The consolidated cases are located in the Eastern District of Pennsylvania, near Novo Nordisk’s New Jersey headquarters.

The passing of U.S. District Judge Gene E. K. Pratter, who initially presided over the MDL, resulted in a temporary delay, as the mantle passed to Judge Karen Spence Marston. The situation is substantial, with the potential for the MDL to grow to up to 10,000 lawsuits. The impact on New Jersey cases is notable, as each ruling within the MDL could set precedents that influence local plaintiffs.

Mounjaro Lawsuit Settlement Amounts in New Jersey

Many wonder what a Mounjaro lawsuit might yield in terms of settlement amounts. The answer is as varied as the individual stories of suffering, with estimates ranging from $350,000 to over a million dollars.

The severity of injuries is a key determinant, with the more serious cases potentially commanding settlements between $400,000 and $700,000. However, there is no one-size-fits-all figure; each case is unique and influenced by factors such as personal loss, pain, and financial hardship.

In the realm of Mounjaro settlements, the details matter. The value of each case is intricately tied to the specific losses and injuries suffered, including tangible factors such as medical expenses.

New Jersey offers no cap on compensatory damages in medical malpractice cases, but punitive damages are capped at either $350,000 or five times the compensatory amount, whichever is greater. This balance aims to ensure justice is served without opening the floodgates to excessive compensation.

Filing a Mounjaro Stomach Paralysis Lawsuit in New Jersey

Filing a Mounjaro stomach paralysis lawsuit in New Jersey involves several procedural steps and important decisions. The state requires a qualified expert’s affidavit before a suit can proceed to court.

Plaintiffs have the flexibility to choose a venue in any county where the defendant has a presence.

The process includes discovery, pre-trial hearings, and settlement negotiations, and if no agreement is reached, it may culminate in a trial.

Types of Evidence To Present

Central to the success of a Mounjaro lawsuit is the quality of evidence presented in court.

Key elements of this evidence include:

  • Medical Records: These documents are crucial. They chronicle the onset of gastroparesis following the use of Mounjaro. They provide a clear timeline of treatment and suffering, forming the foundation of the case.
  • Expert Analysis: Medical records alone might not be enough. Expert analysis often plays a key role, linking the medication to the health issues in a way the court can understand.
  • Hospitalization Accounts: Detailed records of hospital visits highlight the severity and frequency of stomach problems experienced. Each hospital visit, procedure, and recovery period adds weight to the claim.

This isn’t just about numbers or probabilities; it’s about personal stories of pain and the effort to return to normal life. The goal is to prove that Mounjaro was not just a contributing factor but the main cause of health issues and increased hospital visits.

What is the Statute of Limitations for the Mounjaro Lawsuit in New Jersey?

The statute of limitations for the Mounjaro lawsuit in New Jersey is two years. This ticking clock is a critical element in the Mounjaro legal saga. New Jersey sets its rhythm with a timeframe that varies depending on the specifics of each case.

This legal deadline is unforgiving, requiring affected individuals to take swift action or risk being barred from seeking justice. The statute of limitations is not a mere formality; it’s a gatekeeper determining who gets their day in court and who is left standing at the courthouse doors.

Related Articles:

See all related dangerous drug lawsuits our attorneys covered so far.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get Your Free Consultation From Our New Jersey Lawyers

The Schmidt & Clark, LLP law firm is here to support you during these challenging times. If you or a loved one has suffered from gastrointestinal disorders due to weight loss drugs such as Mounjaro, don’t hesitate to reach out to us.

Our team possesses extensive experience in handling such cases and will guide you through the legal proceedings. We will provide clarity regarding your rights and assess your eligibility for a lawsuit related to these complications.

Receive a free case evaluation, and remember, we only charge fees if we successfully win your case. You can trust that our commitment to your case is as strong as if you were part of our own family. Contact us today for a comprehensive review of your concerns.



Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.